Qubit™ 1X dsDNA 高灵敏度 (HS) 和宽范围 (BR) 定量试剂盒
Invitrogen17万+抗体限时买二赠一，靶点广，灵活用！
Qubit™ 1X dsDNA 高灵敏度 (HS) 和宽范围 (BR) 定量试剂盒
引用和文献 (5)
Invitrogen™

Qubit™ 1X dsDNA 高灵敏度 (HS) 和宽范围 (BR) 定量试剂盒

Green features
与 RNA 相比，Qubit 1X dsDNA HS 和 BR 定量试剂盒对 dsDNA 具有高度选择性，提供了易于使用的配方，可使用100和500次检测规格准确定量 dsDNA。λ 标准品可为多达500份样品提供足够的材料。
Have Questions?
更改视图buttonViewtableView
货号数量检测定量范围
Q33230100 assays1X dsDNA，高灵敏度0.1 至 120 ng
Q33231500 assays1X dsDNA，高灵敏度0.1 至 120 ng
Q33266500 assays1X dsDNA，宽范围4 至 4000 ng
Q33265100 assays1X dsDNA，宽范围4 至 4000 ng
货号 Q33230
价格（CNY)
841.00
飞享价
Ends: 31-Dec-2025
1,423.00
共减 582.00 (41%)
Each
添加至购物车
数量:
100 assays
检测:
1X dsDNA，高灵敏度
定量范围:
0.1 至 120 ng
价格（CNY)
841.00
飞享价
Ends: 31-Dec-2025
1,423.00
共减 582.00 (41%)
Each
添加至购物车
使用 Qubit 1X dsDNA HS（高灵敏度）和 Qubit 1X dsDNA BR（宽范围）定量试剂盒体验简单、精准的 dsDNA 定量。1X 配方提供了即用型工作溶液，可在 Qubit 荧光计上实现简单的 dsDNA 样品定量。相较于 ssDNA、RNA、蛋白和游离核苷酸，这些定量试剂盒对 dsDNA 具有高度选择性。耐受污染物，如盐、溶剂或去污剂。
Qubit 1X dsDNA HS 和 BR 定量试剂盒应与 Qubit 荧光计配合使用，相较于单链 DNA (ssDNA)、RNA、蛋白和游离核苷酸，这些试剂盒对双链 DNA (dsDNA) 具有高度选择性。所有试剂盒均提供即用型工作溶液和 DNA 标准品。进行测定时，只需将您的样品（1–20 µL 的任意体积均可接受）稀释到提供的 1X 工作溶液中，然后就可使用 Qubit 荧光计读取浓度。

Qubit 1X dsDNA HS 定量试剂盒
Qubit dsDNA HS（高灵敏度）定量试剂盒与 Qubit 荧光计配合使用时，可提供一种准确且具有选择性的敏感性 DNA 样品定量方法。该定量试剂盒设计用于准确检测初始浓度为 5 pg/µL 至 120 ng/µL 的 DNA 样品（具体取决于样品量），检测范围为 0.1−120 ng。

Qubit 1X dsDNA BR 定量试剂盒
Qubit dsDNA BR（宽范围）定量试剂盒应与 Qubit 4 或 Qubit Flex 荧光计配合使用，它提供了一种准确且具有选择性的 DNA 样品定量方法。该测定试剂盒设计用于准确检测初始浓度为 0.2 至 4,000 ng/µL 的 DNA 样品（具体取决于样品量），检测范围为 4-4,000 ng。

注
• Qubit 1X dsDNA HS 可与 Qubit 2、Qubit 3、Qubit 4 和 Qubit Flex 荧光计配合使用
• Qubit 1X dsDNA BR 应与 Qubit 4 和 Qubit Flex 荧光计配合使用
• 将透明的薄壁 0.5 mL PCR 管（货号：Q32856）用于 Qubit 4 荧光计，将 200 μL 8联管（货号：Q33252）用于 Qubit Flex 荧光计

仅供科研使用。不可用于诊断程序。
规格
检测1X dsDNA，高灵敏度
适用于（设备）Qubit 2.0、3、4 及 Flex 荧光计
环保功能节省资源、减少浪费
反应次数100 次反应
产品线Qubit
定量范围0.1 至 120 ng
数量100 assays
运输条件湿冰
Unit SizeEach

常见问题解答 (FAQ)

What is the expiration date for Qubit 1X dsDNA High Sensitivity (HS) and Broad Range (BR) Assay Kits (Cat. Nos. Cat. Q33230, Q33231, Q33265, Q33266)?

The Qubit 1X dsDNA High Sensitivity (HS) and Broad Range (BR) Assay Kits (Cat. Nos. Cat. Q33230, Q33231, Q33265, Q33266) are stable for 6 months from the date of receipt when stored as directed.

For more information on product storage, please refer to the user guides:

Qubit 1X dsDNA HS Assay Kit and Qubit 1X dsDNA BR Assay Kit

Find additional tips, troubleshooting help, and resources within our Nucleic Acid Quantification Support Center.

What is the difference between The Qubit 1X dsDNA High Sensitivity (HS) and Broad Range (BR) Assay Kits (Cat. Nos. Q33230, Q33231, Q33265, Q33366) and Qubit dsDNA Quantification Assay Kits (Cat. Nos. Q32850, Q32851, Q32853, Q32854)?

The Qubit 1X dsDNA High Sensitivity (HS) and Broad Range (BR) Assay Kits (Cat. Nos. Q33230, Q33231, Q33265, Q33366) are newer and have a simplified workflow compared to the original Qubit dsDNA Quantification Assay Kits (Cat. Nos. Q32850, Q32851, Q32853, Q32854). The original Qubit kits contain separate dyes and buffer components that must be mixed together to make a working solution, in which the dye degrades after a few hours. With the newer Qubit 1X dsDNA Assay kits, the dye is premixed with a buffer that keeps the dye stable long-term and can be added directly to DNA samples.

You can find more information about the Qubit 1X dsDNA assay, by clicking on the Technical Note provided below:

Qubit 1X dsDNA assays: simplified workflow and improved performance

Find additional tips, troubleshooting help, and resources within our Nucleic Acid Quantification Support Center.

How should I store my Qubit 1X dsDNA High Sensitivity (HS) and Broad Range (BR) Assay Kits (Cat. No. Q33230, Q33231, Q33265, Q33266)?

The Qubit 1X dsDNA High Sensitivity (HS) (Cat. Nos. Q33230, Q33231) and Broad Range (BR) Assay Kits (Cat. Nos. Q33265, Q33266) have different storage conditions.

For Qubit 1X dsDNA HS Assay Kits (Cat. Nos. Q33230, Q33231), store all components at 2 - 8 degrees C.

For Qubit 1X dsDNA BR Assay Kits (Cat. Nos. Q33265, Q33266), store the working solution at 18 - 28 degrees C. Store the standards at 2 - 8 degrees C.

The assay kits are stable for at least 6 months from the date of receipt.

For more information, please refer to these user guides: Qubit 1X dsDNA HS Assay Kit and Qubit 1X dsDNA BR Assay Kit

Find additional tips, troubleshooting help, and resources within our Nucleic Acid Quantification Support Center.

引用和文献 (5)

引用和文献
Abstract
Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.
Authors:Skaro M, Nanda N, Gauthier C, Felsenstein M, Jiang Z, Qiu M, Shindo K, Yu J, Hutchings D, Javed AA, Beckman R, He J, Wolfgang CL, Thompson E, Hruban RH, Klein AP, Goggins M, Wood LD, Roberts NJ
Journal:Gastroenterology
PubMed ID:30716324
'Many patients with pancreatic adenocarcinoma carry germline mutations associated with increased risk of cancer. It is not clear whether patients with intraductal papillary mucinous neoplasms (IPMNs), which are precursors to some pancreatic cancers, also carry these mutations. We assessed the prevalence of germline mutations associated with cancer risk in patients ... More
Unravelling the Role of Trophoblastic-Derived Extracellular Vesicles in Regulatory T Cell Differentiation.
Authors:Kovács ÁF, Fekete N, Turiák L, Ács A, Kohidai L, Buzás EI, Pállinger É
Journal:Int J Mol Sci
PubMed ID:31337116
'Regulatory T cells (T'
Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.
Authors:Lu J, du Plessis L, Liu Z, Hill V, Kang M, Lin H, Sun J, François S, Kraemer MUG, Faria NR, McCrone JT, Peng J, Xiong Q, Yuan R, Zeng L, Zhou P, Liang C, Yi L, Liu J, Xiao J, Hu J, Liu T, Ma W, Li W, Su J, Zheng H, Peng B, Fang S, Su W, Li K, Sun R, Bai R, Tang X, Liang M, Quick J, Song T, Rambaut A, Loman N, Raghwani J, Pybus OG, Ke C
Journal:Cell
PubMed ID:32359424
'Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first reported in central China in December 2019. Extensive molecular surveillance in Guangdong, China''s most populous province, during early 2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the molecular epidemiology and genetic ... More
The Application of Nanopore Sequencing Technology to the Study of Dinoflagellates: A Proof of Concept Study for Rapid Sequence-Based Discrimination of Potentially Harmful Algae.
Authors:Hatfield RG, Batista FM, Bean TP, Fonseca VG, Santos A, Turner AD, Lewis A, Dean KJ, Martinez-Urtaza J
Journal:Front Microbiol
PubMed ID:32457722
'Harmful algal blooms (HABs) are a naturally occurring global phenomena that have the potential to impact fisheries, leisure and ecosystems, as well as posing a significant hazard to animal and human health. There is significant interest in the development and application of methodologies to study all aspects of the causative ... More
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.
Authors:Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O'Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Galling
Journal:Cancer Cell
PubMed ID:30686769
We integrated clinical, genomic, and transcriptomic data from 224 primaries and 95 metastases from 289 patients to characterize progression of pancreatic ductal adenocarcinoma (PDAC). Driver gene alterations and mutational and expression-based signatures were preserved, with truncations, inversions, and translocations most conserved. Cell cycle progression (CCP) increased with sequential inactivation of ... More